ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.

Eitemau Tebyg

• ER-α36, a Novel Variant of ER-α, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKCδ/ERK Pathway
  gan: Tong, Jing-Shan, et al.
  Cyhoeddwyd: (2010)
• Estrogen receptor-alpha (ER-α) suppresses expression of its variant ER-α36
  gan: Zou, Yi, et al.
  Cyhoeddwyd: (2009)
• ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways
  gan: Lin, Sheng-Li, et al.
  Cyhoeddwyd: (2010)
• Involvement of Estrogen Receptor Variant ER-α36, Not GPR30, in Nongenomic Estrogen Signaling
  gan: Kang, Lianguo, et al.
  Cyhoeddwyd: (2010)
• A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells
  gan: Lin, Sheng-Li, et al.
  Cyhoeddwyd: (2009)